BMEA · Biomea Fusion, Inc. · Held by Funds
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended June 30, 2026, our management has concluded that there is substantial doubt as to whether we can continue as a going concern for the twelve months following the issuance of this Quarterly Report on Form 10-Q. Our ability to continue as a going concern is dependent upon raising capital to maintain current operations and continue research and development efforts. We plan to raise additional capital to fund our operations through public or private equity offerings, debt financings, and/or potential collaborations and license arrangement or other sources. There is no assurance, however, that any additional financing or any revenue-generating collaboration will be available when needed or that we will be able to obtain financing or enter into a collaboration on terms acceptable to us. Based on our current operating plan, we will not be able to continue as a going concern over the next twelve months unless we raise additional capital by other means. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of BMEA by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 5.05% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.93% | 672,476 |
| Index ETFs | 4.12% | 2,987,242 |
| Active ETFs | 0.00% | 0 |
| Active funds | 6.95% | 5,035,735 |
| Unclassified | 0.00% | 0 |
| All registered funds | 12.00% | 8,695,453 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding BMEA
26 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 2,711,793 | $3,742,274 | 0.00% | Long | 2026-05-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,122,086 | $3,119,466 | 0.00% | Long | 2026-06-30 | |
| Fidelity Growth Company K6 Fund | FGKFX | 907,147 | $1,251,863 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | FCGSX | 804,702 | $1,110,489 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 634,141 | $932,187 | 0.00% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 452,663 | $624,675 | 0.01% | Long | 2026-05-31 | |
| Fidelity Extended Market Index Fund | FSMAX | 291,584 | $402,386 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | IWC | 231,015 | $339,592 | 0.02% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 109,135 | $150,606 | 0.00% | Long | 2026-05-31 | |
| Ultra-Small Company Market Fund | BRSIX | 84,600 | $124,362 | 0.08% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | FCFMX | 82,413 | $113,730 | 0.00% | Long | 2026-05-31 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 59,251 | $87,099 | 0.00% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 51,944 | $71,683 | 0.00% | Long | 2026-05-31 | |
| Range Cancer Therapeutics ETF | CNCR | 19,723 | $56,999 | 0.64% | Long | 2025-02-28 | |
| VANGUARD BALANCED INDEX FUND | — | 37,201 | $54,685 | 0.00% | Long | 2026-06-30 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 36,499 | $53,654 | 0.00% | Long | 2026-06-30 | |
| Fidelity ZERO Total Market Index Fund | FZROX | 28,793 | $33,688 | 0.00% | Long | 2026-07-31 | |
| 1290 VT Micro Cap Portfolio | — | 15,579 | $22,901 | 0.01% | Long | 2026-06-30 | |
| Fidelity ZERO Extended Market Index Fund | FZIPX | 18,616 | $21,781 | 0.00% | Long | 2026-07-31 | |
| Fidelity Flex Small Cap Index Fund | FLXSX | 10,399 | $12,167 | 0.00% | Long | 2026-07-31 | |
| Principal Healthcare Innovators ETF | — | 1,541 | $6,935 | 0.04% | Long | 2024-06-30 | |
| VIP Extended Market Index Portfolio | — | 4,006 | $5,889 | 0.00% | Long | 2026-06-30 | |
| Small-Mid Cap Equity Fund | TSGUX | 719 | $5,206 | 0.00% | Long | 2024-11-30 | |
| Total Stock Market Index Trust | — | 1,444 | $2,123 | 0.00% | Long | 2026-06-30 | |
| VIP Total Market Index Portfolio | — | 1,375 | $2,021 | 0.00% | Long | 2026-06-30 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 383 | $448 | 0.00% | Long | 2026-07-31 |